Show simple item record

dc.creatorMirjanić-Azarić, Bosa
dc.creatorVekić, Jelena
dc.creatorZeljković, Aleksandra
dc.creatorJelić-Ivanović, Zorana
dc.creatorĐerić, Mirjana
dc.creatorMilivojac, Tatjana
dc.creatorFonović, Ursa Pecar
dc.creatorMarc, Janja
dc.creatorKos, Janko
dc.creatorCerne, Darko
dc.date.accessioned2019-09-02T11:38:16Z
dc.date.available2019-09-02T11:38:16Z
dc.date.issued2014
dc.identifier.issn1340-3478
dc.identifier.urihttp://farfar.pharmacy.bg.ac.rs/handle/123456789/2069
dc.description.abstractAim: We hypothesized that, in stable angina patients, atorvastatin therapy lowers the cathepsin S (CTSS) concentrations, as assessed non-invasively according to a plasma analysis. In addition, the low-density lipoprotein (LDL) and high-density lipoprotein (HDL) size and subclasses in the plasma were analysed to establish the association between CTSS and lipoprotein metabolism and determine whether this association is atorvastatin-sensitive. Methods: A total of 43 patients with stable angina received atorvastatin therapy (20 mg/day, 10 weeks). The plasma CTSS mRNA levels, CTSS protein concentrations and CTSS activity, as well as LDL and HDL size and subclasses, were analysed before and after treatment. Results: Atorvastatin treatment did not change the plasma CTSS mRNA levels, although it lowered the plasma CTSS concentrations and activity. An increased plasma CTSS concentration and activity were found to be associated with a more atherogenic LDL subclass profile (a decreased dominant LDL size and increased percentage of small, dense LDL particles). The atorvastatin-induced CTSS-lowering effect was concomitant with an improvement in the LDL subclass profile, and the changes were found to be interrelated. Concomitant, interrelated changes in the CTSS levels and LDL subclass profiles were found in the LDL phenotype B patients only (a dominant LDL diameter of lt = 25.5 nm at the start of the study). In this subgroup, lowering of the plasma CTSS mRNA level also correlated with lowering of the proportion of small, dense LDL particles. Conclusions: Atorvastatin-induced CTSS-lowering and LDL subclass profile improvements in the plasma of LDL phenotype B patients with stable angina are concomitant and interrelated.en
dc.publisherJapan Atherosclerosis Soc, Tokyo
dc.relationAd Futura - Scientific and Educational Foundation of the Republic of Slovenia, the Slovenian Research Agency, Republic of Slovenia grant P4-0127
dc.rightsopenAccess
dc.sourceJournal of Atherosclerosis and Thrombosis
dc.subjectAtorvastatinen
dc.subjectCathepsin Sen
dc.subjectLDL subclassesen
dc.subjectLDL phenotypeen
dc.titleInterrelated Cathepsin S-Lowering and LDL Subclass Profile Improvements Induced by Atorvastatin in the Plasma of Stable Angina Patientsen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractЗељковић, Aлександра; Ђерић, Мирјана; Јелић-Ивановић, Зорана; Миливојац, Татјана; Марц, Јања; Фоновић, Урса Пецар; Кос, Јанко; Векић, Јелена; Мирјанић-Aзарић, Боса; Церне, Дарко;
dc.citation.volume21
dc.citation.issue8
dc.citation.spage868
dc.citation.epage877
dc.citation.other21(8): 868-877
dc.citation.rankM22
dc.identifier.wos000342071100009
dc.identifier.doi10.5551/jat.21410
dc.identifier.pmid24727728
dc.identifier.scopus2-s2.0-84906810476
dc.identifier.fulltexthttp://farfar.pharmacy.bg.ac.rs//bitstream/id/813/2067.pdf
dc.identifier.rcubconv_3157
dc.type.versionpublishedVersion


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record